A Pharmaceutical Cannabidiol Company

A leader in the production of pharmaceutical cannabidiol
and the development of innovative cannabidiol medicines
for heart disease

Pharmaceutical CBD

Developing CardiolRxTM for the rapidly growing medicinal cannabinoids market.

Acute Myocarditis

Cardiol is planning an international clinical study of acute myocarditis, the most common cause of sudden cardiac death in people under 35 years of age.

Heart Failure

Committed to conquering a serious condition that affects more than 26 million people globally.